IBDEI0FX ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21389,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,21389,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,21389,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,21390,0)
 ;;=V19.0^^137^1232^6
 ;;^UTILITY(U,$J,358.3,21390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21390,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,21390,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,21390,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,21391,0)
 ;;=V16.3^^137^1232^7
 ;;^UTILITY(U,$J,358.3,21391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21391,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,21391,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,21391,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,21392,0)
 ;;=V16.41^^137^1232^10
 ;;^UTILITY(U,$J,358.3,21392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21392,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,21392,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,21392,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,21393,0)
 ;;=V16.42^^137^1232^11
 ;;^UTILITY(U,$J,358.3,21393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21393,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,21393,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,21393,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,21394,0)
 ;;=V16.43^^137^1232^12
 ;;^UTILITY(U,$J,358.3,21394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21394,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,21394,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,21394,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,21395,0)
 ;;=V19.5^^137^1232^13
 ;;^UTILITY(U,$J,358.3,21395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21395,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,21395,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,21395,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,21396,0)
 ;;=V19.2^^137^1232^14
 ;;^UTILITY(U,$J,358.3,21396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21396,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,21396,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,21396,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,21397,0)
 ;;=V17.3^^137^1232^16
 ;;^UTILITY(U,$J,358.3,21397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21397,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,21397,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,21397,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,21398,0)
 ;;=V16.6^^137^1232^17
 ;;^UTILITY(U,$J,358.3,21398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21398,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,21398,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,21398,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,21399,0)
 ;;=V18.61^^137^1232^19
 ;;^UTILITY(U,$J,358.3,21399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21399,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,21399,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,21399,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,21400,0)
 ;;=V17.0^^137^1232^20
 ;;^UTILITY(U,$J,358.3,21400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21400,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,21400,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,21400,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,21401,0)
 ;;=V19.4^^137^1232^21
 ;;^UTILITY(U,$J,358.3,21401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21401,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,21401,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,21401,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,21402,0)
 ;;=V17.1^^137^1232^22
 ;;^UTILITY(U,$J,358.3,21402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21402,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,21402,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,21402,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,21403,0)
 ;;=V16.8^^137^1232^18
 ;;^UTILITY(U,$J,358.3,21403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21403,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,21403,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,21403,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,21404,0)
 ;;=V11.1^^137^1232^41
 ;;^UTILITY(U,$J,358.3,21404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21404,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,21404,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,21404,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,21405,0)
 ;;=V15.89^^137^1232^49
 ;;^UTILITY(U,$J,358.3,21405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21405,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,21405,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,21405,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,21406,0)
 ;;=V11.3^^137^1232^42
 ;;^UTILITY(U,$J,358.3,21406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21406,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,21406,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,21406,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,21407,0)
 ;;=V15.07^^137^1232^43
 ;;^UTILITY(U,$J,358.3,21407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21407,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,21407,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,21407,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,21408,0)
 ;;=V13.4^^137^1232^44
 ;;^UTILITY(U,$J,358.3,21408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21408,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,21408,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,21408,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,21409,0)
 ;;=V12.72^^137^1232^45
 ;;^UTILITY(U,$J,358.3,21409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21409,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,21409,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,21409,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,21410,0)
 ;;=V12.59^^137^1232^46
 ;;^UTILITY(U,$J,358.3,21410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21410,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,21410,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,21410,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,21411,0)
 ;;=V45.81^^137^1232^47
 ;;^UTILITY(U,$J,358.3,21411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21411,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,21411,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,21411,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,21412,0)
 ;;=V15.84^^137^1232^48
 ;;^UTILITY(U,$J,358.3,21412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21412,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,21412,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,21412,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,21413,0)
 ;;=V15.85^^137^1232^53
 ;;^UTILITY(U,$J,358.3,21413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21413,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,21413,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,21413,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,21414,0)
 ;;=V10.72^^137^1232^51
 ;;^UTILITY(U,$J,358.3,21414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21414,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,21414,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,21414,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,21415,0)
 ;;=V15.3^^137^1232^52
 ;;^UTILITY(U,$J,358.3,21415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21415,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,21415,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,21415,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,21416,0)
 ;;=V10.61^^137^1232^26
 ;;^UTILITY(U,$J,358.3,21416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21416,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,21416,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,21416,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,21417,0)
 ;;=V12.03^^137^1232^27
 ;;^UTILITY(U,$J,358.3,21417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21417,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,21417,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,21417,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,21418,0)
 ;;=V10.82^^137^1232^28
 ;;^UTILITY(U,$J,358.3,21418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21418,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,21418,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,21418,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,21419,0)
 ;;=V10.62^^137^1232^30
 ;;^UTILITY(U,$J,358.3,21419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21419,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,21419,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,21419,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,21420,0)
 ;;=V10.63^^137^1232^29
 ;;^UTILITY(U,$J,358.3,21420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21420,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,21420,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,21420,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,21421,0)
 ;;=V11.2^^137^1232^24
 ;;^UTILITY(U,$J,358.3,21421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21421,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,21421,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,21421,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,21422,0)
 ;;=V15.81^^137^1232^40
 ;;^UTILITY(U,$J,358.3,21422,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21422,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,21422,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,21422,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,21423,0)
 ;;=V10.43^^137^1232^31
 ;;^UTILITY(U,$J,358.3,21423,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21423,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,21423,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,21423,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,21424,0)
 ;;=V12.71^^137^1232^32
 ;;^UTILITY(U,$J,358.3,21424,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21424,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,21424,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,21424,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,21425,0)
 ;;=V10.46^^137^1232^33
